KeyCorp has released a new outlook for Viper Energy’s second-quarter 2027 results, predicting earnings of $0.66 per share. Alongside this figure, the firm maintains an “Overweight” rating on the oil and gas producer, signaling confidence in its upcoming performance.

Cantor Fitzgerald has reaffirmed its ‘overweight’ rating on Capricor Therapeutics (NASDAQ: CAPR). The brokerage set a $30 price target and estimated FY2025 earnings at $1.71 per share.